Amgen names Bradway chairman, ups dividend

Amgen Inc. (NASDAQ:AMGN) named CEO Robert Bradway as chairman, effective Jan. 1, 2013. Bradway took over as CEO of the biotech in May, replacing Kevin Sharer, who retired as CEO and chairman.

The company's board also declared a 1Q13 dividend of $0.47 per share, up 31% from the prior quarter's dividend of $0.36. The dividend will be paid on March 7, 2013, to shareholders of record as of Feb. 13, 2013. Amgen's board also authorized the repurchase of an additional $2 billion of the company's shares, on top of the roughly $500 million remaining under a $10 billion share repurchase program. At Oct. 29, Amgen had 767.4 million shares outstanding. ...